# Effects of Prescription Omega-3 Acids on Glucose and Lipoprotein Lipids in Subjects With Hypertriglyceridemia

> **NCT01034540** · NA · COMPLETED · sponsor: **Provident Clinical Research** · enrollment: 23 (actual)

## Conditions studied

- Hypertriglyceridemia

## Interventions

- **DRUG:** POM3
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01034540
- **Lead sponsor:** Provident Clinical Research
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2010-12
- **Final completion:** 2011-02
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2024-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01034540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01034540, "Effects of Prescription Omega-3 Acids on Glucose and Lipoprotein Lipids in Subjects With Hypertriglyceridemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01034540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*